ExodusPoint Capital Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
ExodusPoint Capital Management's ATRC Position: Q3 2026 in Review
ExodusPoint Capital Management sold out of AtriCure (ATRC) in Q3 2026, closing a stake of 86,356 shares — an estimated $2.42M sold.
ExodusPoint Capital Management first reported a position in ATRC in Q1 2020 and held it in 16 quarters. The position peaked at $10.5M in Q4 2021. 286 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.
- ExodusPoint Capital Management reported no remaining AtriCure position as of Q3 2026 after selling out during the quarter.
- ExodusPoint Capital Management sold 86,356 AtriCure shares in Q3 2026, an estimated $2.42M.
- ExodusPoint Capital Management first reported a position in AtriCure in Q1 2020 and held it in 16 quarters.
- ExodusPoint Capital Management's AtriCure position peaked at $10.5M in Q4 2021.
- 286 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.
Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.